BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

309 related articles for article (PubMed ID: 8679557)

  • 1. Formation of the amino acid-DNA complexes by hexavalent and trivalent chromium in vitro: importance of trivalent chromium and the phosphate group.
    Zhitkovich A; Voitkun V; Costa M
    Biochemistry; 1996 Jun; 35(22):7275-82. PubMed ID: 8679557
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glutathione and free amino acids form stable complexes with DNA following exposure of intact mammalian cells to chromate.
    Zhitkovich A; Voitkun V; Costa M
    Carcinogenesis; 1995 Apr; 16(4):907-13. PubMed ID: 7728973
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of neutral, cationic, and anionic chromium ascorbate complexes on isolated human mitochondrial and genomic DNA.
    Ay AN; Zümreoglu-Karan B; Oner R; Unaleroglu C; Oner C
    J Biochem Mol Biol; 2003 Jul; 36(4):403-8. PubMed ID: 12895300
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypoxia impedes the formation of chromium DNA-adducts in a cell-free system.
    O'Brien TJ; Mandel HG; Sugden KD; Komarov AM; Patierno SR
    Biochem Pharmacol; 2005 Dec; 70(12):1814-22. PubMed ID: 16242673
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incision of trivalent chromium [Cr(III)]-induced DNA damage by Bacillus caldotenax UvrABC endonuclease.
    O'Brien TJ; Jiang G; Chun G; Mandel HG; Westphal CS; Kahen K; Montaser A; States JC; Patierno SR
    Mutat Res; 2006 Nov; 610(1-2):85-92. PubMed ID: 16890479
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of nonmutagenic Cr(III)-DNA interactions.
    Blankert SA; Coryell VH; Picard BT; Wolf KK; Lomas RE; Stearns DM
    Chem Res Toxicol; 2003 Jul; 16(7):847-54. PubMed ID: 12870887
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mobility and recalcitrance of organo-chromium(III) complexes.
    Puzon GJ; Tokala RK; Zhang H; Yonge D; Peyton BM; Xun L
    Chemosphere; 2008 Feb; 70(11):2054-9. PubMed ID: 17959226
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of the binding sites of chromium to DNA and protein in vitro and in intact cells.
    Salnikow K; Zhitkovich A; Costa M
    Carcinogenesis; 1992 Dec; 13(12):2341-6. PubMed ID: 1473242
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chromium(III) decreases the fidelity of human DNA polymerase beta.
    Singh J; Snow ET
    Biochemistry; 1998 Jun; 37(26):9371-8. PubMed ID: 9649318
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Isolation and characterization of an NAD+-degrading bacterium PTX1 and its role in chromium biogeochemical cycle.
    Puzon GJ; Huang Y; Dohnalkova A; Xun L
    Biodegradation; 2008 Jun; 19(3):417-24. PubMed ID: 17701280
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Examining the Potential Formation of Ternary DNA Complexes with Chromium‑Cysteine, Chromium-Ascorbate, and Chromium-Glutathione and Implications for Their Carcinogenicity.
    Marchi S; Lankford E; Dorin B; Drummond E; Thomas SC; Woski SA; Vincent JB
    Biol Trace Elem Res; 2023 Oct; 201(10):5053-5066. PubMed ID: 36662348
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Carcinogenic chromium(VI) induces cross-linking of vitamin C to DNA in vitro and in human lung A549 cells.
    Quievryn G; Messer J; Zhitkovich A
    Biochemistry; 2002 Mar; 41(9):3156-67. PubMed ID: 11863455
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Non-oxidative mechanisms are responsible for the induction of mutagenesis by reduction of Cr(VI) with cysteine: role of ternary DNA adducts in Cr(III)-dependent mutagenesis.
    Zhitkovich A; Song Y; Quievryn G; Voitkun V
    Biochemistry; 2001 Jan; 40(2):549-60. PubMed ID: 11148050
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pro-oxidative vs antioxidative properties of ascorbic acid in chromium(VI)-induced damage: an in vivo and in vitro approach.
    Poljsak B; Gazdag Z; Jenko-Brinovec S; Fujs S; Pesti M; Bélagyi J; Plesnicar S; Raspor P
    J Appl Toxicol; 2005; 25(6):535-48. PubMed ID: 16092082
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Unusual reactivity in a commercial chromium supplement compared to baseline DNA cleavage with synthetic chromium complexes.
    Chaudhary S; Pinkston J; Rabile MM; Van Horn JD
    J Inorg Biochem; 2005 Mar; 99(3):787-94. PubMed ID: 15708800
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Solution structures of chromium(VI) complexes with glutathione and model thiols.
    Levina A; Lay PA
    Inorg Chem; 2004 Jan; 43(1):324-35. PubMed ID: 14704084
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Examining the Potential Formation of Ternary Chromium-Histidine-DNA Complexes and Implications for Their Carcinogenicity.
    Lankford E; Thomas CS; Marchi S; Brown S; Woski SA; Vincent JB
    Biol Trace Elem Res; 2022 Mar; 200(3):1473-1481. PubMed ID: 33948897
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genotoxicity and mutagenicity of chromium(VI)/ascorbate-generated DNA adducts in human and bacterial cells.
    Quievryn G; Peterson E; Messer J; Zhitkovich A
    Biochemistry; 2003 Feb; 42(4):1062-70. PubMed ID: 12549927
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reductive activation with cysteine represents a chromium(III)-dependent pathway in the induction of genotoxicity by carcinogenic chromium(VI).
    Zhitkovich A; Quievryn G; Messer J; Motylevich Z
    Environ Health Perspect; 2002 Oct; 110 Suppl 5(Suppl 5):729-31. PubMed ID: 12426121
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fe(III) photocatalytic reduction of Cr(VI) by low-molecular-weight organic acids with alpha-OH.
    Sun J; Mao JD; Gong H; Lan Y
    J Hazard Mater; 2009 Sep; 168(2-3):1569-74. PubMed ID: 19372002
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.